Friday, April 19, 2019
News

Aurobindo completes acquisition of Apotex's businesses in 5 European countries

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

| February 11, 2019 1:11:43 PM IST
Aurobindo Pharma, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, on Monday announced that it has closed the acquisition of Apotexs commercial operations and certain supporting infrastructure in five European countries.

The binding agreement to acquire five of Apotex' European businesses including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier license rights in Poland, the Czech Republic, the Netherlands (including the manufacturing facility in Leiden), Spain and Belgium was announced on July 14 last year.

Jefferies International Limited acted as sole financial advisor and Herbert Smith Freehills LLP acted as legal counsel to Aurobindo. Ernst & Young India provided financial due diligence services.

Aurobindo's product portfolio is spread over seven major therapeutic/product areas encompassing antibiotics, antiretrovirals, CVS, CNS, gastroenterologicals, anti-allergies and anti-diabetics. The United States and Europe are Aurobindos two most important markets accounting for over 70 per cent of the companys 2.6 billion dollar sales. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Imran Khan axes Finance Minister amid IM...
Notice to Samsung for not passing GST cu...
Rural India yet to recover from disrupti...
Honda Accord recalls 3,669 units for fal...
Stock markets fall in early trading ahea...
US dollar falls against major currencies...
More...
 
INDIA WORLD ASIA
ED seizes Rs 82 crore gold from Hyderaba...
PIL in SC: Misquoting judicial orders is...
Four possible toehold spots for BJP in K...
Millions vote in second round of Lok Sab...
64% polling recorded in second phase in ...
BJP will get 'Vidai certificate' post po...
More...    
 
 Top Stories
Notice to Samsung for not passing G... 
Siriwardana, Vandersay, Mendis in S... 
Continue to be sensitive to #MeToo ... 
Russell skips training after injuri... 
'Fuh se Fantasy' is different conce... 
PIL in SC: Misquoting judicial orde... 
Four possible toehold spots for BJP... 
Millions vote in second round of Lo...